Join
Live feed
·
INSIDERFilingvia Quantisnow
Sarepta Therapeutics Inc. logo

Chief Customer Officer Murray Dallan converted options into 5,500 shares, covered exercise/tax liability with 3,733 shares and was granted 8,276 shares, increasing direct ownership by 36% to 38,202 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRPT (Sarepta Therapeutics Inc.) and more on Quantisnow.